GGrantIndex
← Leaderboards

Derek L Stirewalt

Fred Hutchinson Cancer Research Center

$11,495,563
Attributed
$13,578,976
Total exposure
8
Grants
7
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2.2M · FY200525
$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$16,355,068 · 9

By mechanism

R01$5,170,691 · 2
U24$4,166,827 · 1
U54$3,694,582 · 3
U19$2,273,640 · 1
K23$618,749 · 1
R21$430,579 · 1

Top collaborators

Most similar at Fred Hutchinson Cancer Research Center

Same institution · by research overlap

Others in their field

Top investigators on “Base

Research focus

BaseCellsEnsureGenesLeadUniversitiesNon-MalignantWeb SiteFundingInnovationCommunitiesHematologyTransplantationResourcesCostResearch PersonnelCharacteristicsProgramsDesignResponseSamplingHematopoiesisTechnologyCytogenetics

Grant awards (35)

Hematology Central Coordinating Center (HCCC) for the NIDDK Hematology Centers Program$1,299,827
U24 · FY2025 · DK
Stem Cell and Transplantation Biology$877,701
U54 · FY2025 · DK · contact PI
Hematology Central Coordinating Center (HCCC) for the NIDDK Hematology Centers Program$867,000
U24 · FY2024 · DK
Stem Cell and Transplantation Biology$632,797
U54 · FY2024 · DK · contact PI
Cell Procurement & Processing$229,625
U54 · FY2024 · DK · contact PI
Hematology Central Coordinating Center (HCCC) for the NIDDK Hematology Centers Program$1,000,000
U24 · FY2023 · DK
Stem Cell and Transplantation Biology$632,797
U54 · FY2023 · DK · contact PI
Cell Procurement & Processing$229,625
U54 · FY2023 · DK · contact PI
Hematology Central Coordinating Center (HCCC) for the NIDDK Hematology Centers Program$1,000,000
U24 · FY2022 · DK
Stem Cell and Transplantation Biology$632,797
U54 · FY2022 · DK · contact PI
Cell Procurement & Processing$229,625
U54 · FY2022 · DK · contact PI
Cell Procurement & Processing$154,161
U54 · FY2021 · DK · contact PI
Cell Procurement & Processing$75,454
U54 · FY2021 · DK · contact PI
Novel Biomarkers to Risk-Stratify AML Patients with NPM1^Pos/FLT3-IT^Neg Genotype$467,801
R01 · FY2020 · CA · contact PI
Novel Biomarkers to Risk-Stratify AML Patients with NPM1^Pos/FLT3-IT^Neg Genotype$504,672
R01 · FY2019 · CA · contact PI
Novel Biomarkers to Risk-Stratify AML Patients with NPM1^Pos/FLT3-IT^Neg Genotype$580,264
R01 · FY2018 · CA · contact PI
Novel Biomarkers to Risk-Stratify AML Patients with NPM1^Pos/FLT3-IT^Neg Genotype$573,343
R01 · FY2017 · CA · contact PI
Novel Biomarkers to Risk-Stratify AML Patients with NPM1^Pos/FLT3-IT^Neg Genotype$576,165
R01 · FY2016 · CA · contact PI
Discovery and Optimization of AML Prognostic Biomarkers$458,821
R01 · FY2016 · CA · contact PI
Discovery and Optimization of AML Prognostic Biomarkers$471,360
R01 · FY2015 · CA · contact PI
Discovery and Optimization of AML Prognostic Biomarkers$470,412
R01 · FY2014 · CA · contact PI
Discovery and Optimization of AML Prognostic Biomarkers$470,557
R01 · FY2013 · CA · contact PI
Discovery and Optimization of AML Prognostic Biomarkers$597,296
R01 · FY2012 · CA · contact PI
IRF8 as a Biomarker of Aging, Malignant Transformation, and AML Prognosis$230,091
R21 · FY2011 · CA · contact PI
IRF8 as a Biomarker of Aging, Malignant Transformation, and AML Prognosis$200,488
R21 · FY2010 · CA · contact PI
Quantitative RT/PCR-based radiation dosimetry$441,308
U19 · FY2009 · AI · contact PI
Quantitative RT/PCR-based radiation dosimetry$448,208
U19 · FY2008 · AI · contact PI
Quantitative RT/PCR-based radiation dosimetry$489,905
U19 · FY2007 · AI · contact PI
Quantitative RT/PCR-based radiation dosimetry$457,915
U19 · FY2006 · AI · contact PI
Examination of FLT3 Mutations in Acute Myeloid Leukemia$106,650
K23 · FY2006 · CA · contact PI
Quantitative RT/PCR-based radiation dosimetry$436,304
U19 · FY2005 · AI
Examination of FLT3 Mutations in Acute Myeloid Leukemia$111,149
K23 · FY2005 · CA
Examination of FLT3 Mutations in Acute Myeloid Leukemia$133,650
K23 · FY2004 · CA
Examination of FLT3 Mutations in Acute Myeloid Leukemia$133,650
K23 · FY2003 · CA
Examination of FLT3 Mutations in Acute Myeloid Leukemia$133,650
K23 · FY2002 · CA